Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-01-04 @ 5:30 AM
Study NCT ID:
NCT03559257
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2018-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-31
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-06
First Submit QC Date:
None
Study First Post Date:
2018-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-06-19
Results First Submit QC Date:
None
Results First Post Date:
2020-07-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-19
Last Update Post Date:
2020-07-08
Last Update Post Date Type:
ACTUAL